IP finance is used by a range of rights holders as a means of turning the patents they hold into income. Typical users include:
Even at companies with substantial patent portfolios, many patents that are not practiced in-house, or that are used by others without a license, generate maintenance costs rather than income. IP finance allows these patents to be monetized without drawing on IP and legal budgets or operating capital. It is also used for portfolios that have become non-core following a business reorganization.
Universities and public research institutions hold valuable patents arising from fundamental research, but have limited budgets and resources for licensing and enforcement. IP finance allows them to obtain fair value for their research without affecting research or operating budgets, and to reinvest the proceeds in further research. Where an SPV is used, the SPV conducts the monetization as the party, so the institution does not, as a rule, itself have to negotiate or litigate.
For start-ups and smaller companies built on proprietary technology, unlicensed use of their patents by a better-resourced company can threaten the business itself, yet few are able to fund several years of negotiation and litigation from their own resources. IP finance enables them to seek fair value for their technology through negotiation and enforcement conducted by specialists, without depleting operating capital.
IP finance allows a rights holder to generate income from its patents without funding the cost of monetization itself. The principal advantages are set out below.
The fund provides the cost of monetization on a non-recourse basis. If the program is unsuccessful, or a patent is held invalid, the rights holder is not required to repay those costs.
Patents that are not practiced in-house incur maintenance costs without generating income. IP finance turns them into assets that produce royalties and settlements.
Generates income from existing assets without additional investment. Proceeds can be reinvested in research and development, creating a cycle of recovery and reinvestment.
The fund's specialist team undertakes the investigation of infringing use, licensing negotiations, and the administration of agreements and royalty collection, reducing the cost and workload of IP management.
Valuation, strategy, negotiation, litigation and collection are carried out end to end with specialists experienced in each jurisdiction. Where an SPV is used, it acts as the party, so the rights holder does not have to face the counterparty directly.
The capital and capability to enforce where necessary help bring licensing negotiations to a conclusion. Negotiated resolution comes first; litigation is the means used where agreement cannot be reached.
Patents are territorial rights, and the level of damages and the availability of injunctions differ significantly between jurisdictions. We select the most effective jurisdictions for the rights held, and pursue licensing and enforcement across the United States, Europe and Asia.
Proceeds are shared between the rights holder and the fund in agreed proportions. As the fund's return depends on the outcome of the monetization, the interests of both are aligned.
IP finance can be provided while the rights holder retains its patents, with the fund financing the cost of monetization, or by bringing the patents into a framework operated by the fund. Depending on the rights holder's objectives and the nature of the patents, the latter takes three principal forms.
The fund establishes a special purpose vehicle (SPV) for each matter. The SPV takes an assignment of the patents from the rights holder and monetizes them with the fund's capital and expertise. Proceeds are shared between the rights holder and the fund in agreed proportions. Assets and risks are ring-fenced matter by matter.
Patents held by multiple rights holders, typically patents essential to a technical standard, are brought together in a single framework and licensed to implementers as a package. The fund finances the formation and operation of the pool. Implementers obtain the licenses they need without negotiating with each rights holder individually, and rights holders receive their share of the income without the burden of licensing negotiations.
The fund, through an SPV, purchases patents or portfolios that have become non-core, for example following a business reorganization, and monetizes them. Consideration takes the form of an upfront payment, a share of subsequent proceeds, or a combination, agreed case by case.
01SPV monetization structure
02Patent pool structure
Our process for IP finance comprises four stages: initial review, due diligence and negotiation of terms, investment committee approval and structuring, and monetization. Each stage is summarized below.
01
02
03
04
IP finance is a means of monetizing patents held by companies and universities, through licensing and enforcement, using the capital and expertise of a fund. The fund provides the cost on a non-recourse basis, and the proceeds are shared between the rights holder and the fund in agreed proportions.
Patents are the principal focus, from a single patent to portfolios spanning multiple technologies and jurisdictions, including standard-essential patents (SEPs). Disputes relating to trade secrets, trademarks, copyright and other rights are considered under litigation finance.
It depends on the structure. In SPV monetization and patent acquisition, the patents are assigned to an SPV and then monetized. In SPV monetization, the rights holder receives a share of the proceeds and can retain the licenses it needs for its own business. In a patent pool, rights holders typically retain ownership of their patents and authorize the pool to grant licenses. There are also arrangements in which the rights holder retains the patents and the fund finances licensing and enforcement. The appropriate structure is discussed in light of the rights holder's objectives.
As a rule, no. The cost of investigation, negotiation and litigation is funded by the fund, and if the patents are not successfully monetized there is nothing to repay. Rights holders may be asked for reasonable cooperation, such as access to inventors and relevant documents.
Typically, the costs funded by the fund are first recovered from the royalties, settlements and damages received, and the balance is shared between the rights holder and the fund in agreed proportions. The proportions and terms are agreed case by case, having regard to the patents and their market.
Licensing through negotiation comes first. Litigation is used as a means of enforcement only where agreement cannot be reached. In SPV monetization, the SPV is the party to any litigation.
The validity of the patents, the prospects of establishing infringement, the sales of the accused products and the likely damages, the remaining patent term, the counterparty's ability to pay, the appropriate jurisdiction, and the cost and time required. We also review title to the patents, including any co-ownership, the terms of any existing licenses and any licensing commitments made to standard-setting organizations.
A list of the patents, including foreign counterparts, the products, services and companies believed to be using them, supporting evidence of infringement such as claim charts, and the history of any licensing, negotiations and disputes. We are happy to have an initial discussion before these materials are complete.
Yes. Patents held by Japanese companies, universities and research institutions are a particular focus for us. Where corresponding rights have been granted in major jurisdictions such as the United States and Europe, monetization in those jurisdictions can be considered.
A loan must be repaid with interest regardless of the outcome. IP finance is non-recourse: the fund's return arises only where the patents are successfully monetized. The underwriting also differs, focusing on the strength of the patents and the prospects of monetization rather than on the borrower's credit.